azacitidine - Generic mfg.
vadastuximab talirine (SGN-CD33A) - Seattle Genetics
decitabine - Generic mfg.
Seattle Genetics: Q2 2015 Results (Seattle Genetics, Inc) - Jul 31, 2015 - Anticipated data from P1 trial (NCT01902329) in combination with hypomethylating agents such as Vidaza and Dacogen for AML in 2015 
Anticipated P1 data • Acute Myelogenous Leukemia
http://seekingalpha.com/article/3380445-seattle-genetics-sgen-clay-b-siegall-on-q2-2015-results-earnings-call-transcript?page=5&p=qanda&l=last
 
Jul 31, 2015
 
.